Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized furosemide for clinical improvement in hospitalized COPD exacerbation
IRCT20210730052016N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of furosemide in chronic obstructive pulmonary disease (COPD), sponsored by Hamadan University of Medical Sciences. Started Jun 2025; status: completed.
02
Drugs
furosemide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20210730052016N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210730052016N1.